Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. [electronic resource]
Producer: 20191219Description: 1341-1343 p. digitalISSN:- 1524-4539
- Atherosclerosis -- blood
- Biomarkers -- blood
- Clinical Decision-Making
- Clinical Trials as Topic
- Drug Costs
- Dyslipidemias -- blood
- Eicosapentaenoic Acid -- adverse effects
- Eligibility Determination -- economics
- Humans
- Hypolipidemic Agents -- adverse effects
- Lipids -- blood
- Multicenter Studies as Topic
- Patient Selection
- Risk Factors
- Treatment Outcome
- United States -- epidemiology
- United States Department of Veterans Affairs
- Veterans Health Services
No physical items for this record
Publication Type: Letter; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.